Form 4 for LGVN Longeveron Inc.
Accepted 2022-04-15 00:00:00 ET · period of report 2022-04-13 · accession 0001214659-22-005331 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-15 | 2022-04-13 | LGVN | DS MED LLC | 10% | J - Other | $0.00 | -748.7K | 7.02M | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-13 | J | D | 748,694 | $0.00 | 7,024,208 | D | — | — | (F1) Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock. (F2) Shares distributed to members of DS Med, LLC, for no consideration. |